US weight-loss biotech Kailera now set to raise $600m
NEW YORK: US weight-loss biotech Kailera Therapeutics has reached another financing goal, raising $600m to…
NEW YORK: US weight-loss biotech Kailera Therapeutics has reached another financing goal, raising $600m to…